ARCHIVES

FDA Names Director Of New Center For Tobacco Products

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Reaches Consensus On Organ Systems; DeVita Goes Along

February 4, 1983

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters

May 21, 1982

NCI Channels More Money To CIS, 17 Offices Funded

March 9, 1990

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001